INR 20.96
(-4.86%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | - INR | -100.0% |
2022 | 1151.00 INR | 0.0% |
2021 | - INR | 0.0% |
2020 | - INR | 0.0% |
2019 | - INR | 0.0% |
2018 | - INR | 0.0% |
2017 | - INR | 0.0% |
2016 | - INR | 0.0% |
2015 | - INR | 0.0% |
2014 | - INR | -100.0% |
2013 | 39.08 Thousand INR | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | - INR | 0.0% |
2023 Q4 | - INR | 0.0% |
2023 FY | - INR | -100.0% |
2023 Q1 | - INR | 0.0% |
2023 Q3 | - INR | 0.0% |
2023 Q2 | - INR | 0.0% |
2022 FY | 1151.00 INR | 0.0% |
2022 Q1 | 1151.00 INR | 0.0% |
2022 Q3 | - INR | 0.0% |
2022 Q2 | - INR | -100.0% |
2022 Q4 | - INR | 0.0% |
2021 Q3 | - INR | 0.0% |
2021 Q4 | - INR | 0.0% |
2021 Q2 | - INR | 0.0% |
2021 Q1 | - INR | 0.0% |
2021 FY | - INR | 0.0% |
2020 Q3 | - INR | 0.0% |
2020 Q1 | - INR | 0.0% |
2020 FY | - INR | 0.0% |
2020 Q4 | - INR | 0.0% |
2020 Q2 | - INR | 0.0% |
2019 Q2 | - INR | 0.0% |
2019 FY | - INR | 0.0% |
2019 Q3 | - INR | 0.0% |
2019 Q1 | - INR | 0.0% |
2019 Q4 | - INR | 0.0% |
2018 Q2 | - INR | 0.0% |
2018 FY | - INR | 0.0% |
2018 Q1 | - INR | 0.0% |
2018 Q3 | - INR | 0.0% |
2018 Q4 | - INR | 0.0% |
2017 Q1 | - INR | 0.0% |
2017 Q2 | - INR | 0.0% |
2017 Q4 | - INR | 0.0% |
2017 Q3 | - INR | 0.0% |
2017 FY | - INR | 0.0% |
2016 Q2 | - INR | 0.0% |
2016 Q1 | - INR | 0.0% |
2016 FY | - INR | 0.0% |
2016 Q4 | - INR | 0.0% |
2016 Q3 | - INR | 0.0% |
2015 Q4 | - INR | 0.0% |
2015 FY | - INR | 0.0% |
2015 Q3 | - INR | 0.0% |
2015 Q2 | - INR | 0.0% |
2015 Q1 | - INR | 0.0% |
2014 Q2 | - INR | 0.0% |
2014 Q3 | - INR | 0.0% |
2014 Q4 | - INR | 0.0% |
2014 FY | - INR | -100.0% |
2014 Q1 | - INR | -100.0% |
2013 Q4 | 39.08 Thousand INR | 0.0% |
2013 Q3 | - INR | 0.0% |
2013 Q2 | - INR | 0.0% |
2013 FY | 39.08 Thousand INR | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Alfavision Overseas (India) Limited | 31.27 Million INR | 100.0% |
Biocon Limited | 147.55 Billion INR | 100.0% |
Blue Jet Healthcare Limited | 7.11 Billion INR | 100.0% |
Concord Biotech Limited | 10.16 Billion INR | 100.0% |
Dishman Carbogen Amcis Limited | 26.15 Billion INR | 100.0% |
FERMENTA BIOTECH LIMITED | 3.35 Billion INR | 100.0% |
GENOMIC VALLEY BIOTECH LIMITED | 1.65 Million INR | 100.0% |
Lyka Labs Limited | 1.05 Billion INR | 100.0% |
Panacea Biotec Limited | 5.51 Billion INR | 100.0% |
SAMSRITA LABS LIMITED | - INR | NaN% |
SMS Lifesciences India Limited | 3.05 Billion INR | 100.0% |
Supriya Lifescience Limited | 5.7 Billion INR | 100.0% |
Syngene International Limited | 34.88 Billion INR | 100.0% |
TAKE Solutions Limited | 656.08 Million INR | 100.0% |
Titan Biotech Limited | 1.64 Billion INR | 100.0% |
Transgene Biotek Limited | 2.34 Million INR | 100.0% |
Vanta Bioscience Limited | 97.22 Million INR | 100.0% |